Checkpoint inhibitor-induced eosinophilic fasciitis following high eosinophilia associated with complete response
Rheumatology (Oxford)
.
2019 Oct 1;58(10):1875-1877.
doi: 10.1093/rheumatology/kez164.
Authors
Frédéric Toussaint
1
,
Matthias Hammon
2
,
Michael Erdmann
1
,
Alvaro Moreira
1
,
Michael C Kirchberger
1
,
Gerold Schuler
1
,
Georg Schett
3
,
Lucie Heinzerling
1
Affiliations
1
Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Erlangen, Germany.
2
Department of Radiology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Erlangen, Germany.
3
Department of Rheumatology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Erlangen, Germany.
PMID:
31056673
DOI:
10.1093/rheumatology/kez164
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Aged
Antineoplastic Agents, Immunological / adverse effects*
Eosinophilia / chemically induced*
Fasciitis / chemically induced*
Female
Humans
Melanoma / drug therapy*
Substances
Antineoplastic Agents, Immunological
Supplementary concepts
Eosinophilic Fasciitis